Skip to main content

Table 2 Daily quantity of GI secretions through the NGT (ml, mean ± SD)

From: Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer

NGT secretions

OCT group

SB group

T0

1,515.1 ± 401.2

1,486.2 ± 432.4

T1

563.6 ± 315.1§*

1,206.9 ± 278.2

T2

355.4 ± 205.4§*

808.5 ± 312.6

T3

298.5 ± 189.2§*

783.4 ± 258.6*

  1. *P < 0.05 for comparison with T0; § P < 0.05 for comparison between groups.
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us